Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

HCC subtypes based on the activity changes of immunologic and hallmark gene sets in tumor and nontumor tissues
Jiao Gong, Rong Li, Yaqiong Chen, et al.
Briefings in Bioinformatics (2020) Vol. 22, Iss. 5
Closed Access | Times Cited: 41

Showing 1-25 of 41 citing articles:

Identification and validation of an anoikis-associated gene signature to predict clinical character, stemness, IDH mutation, and immune filtration in glioblastoma
Zhongzheng Sun, Yongquan Zhao, Wei Yan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 69
Identification of m6A- and ferroptosis-related lncRNA signature for predicting immune efficacy in hepatocellular carcinoma
Hongjun Xie, Muqi Shi, Yifei Liu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 41
Comprehensive molecular classification predicted microenvironment profiles and therapy response for HCC
Yihong Chen, Xiangying Deng, Yin Li, et al.
Hepatology (2024) Vol. 80, Iss. 3, pp. 536-551
Open Access | Times Cited: 11
Stratifin promotes the malignant progression of HCC via binding and hyperactivating AKT signaling
Rong Li, Xijing Yan, Wenhui Zhong, et al.
Cancer Letters (2024) Vol. 592, pp. 216761-216761
Closed Access | Times Cited: 4
Machine learning-based detoxification enzymes-related genes prognosis model in breast cancer: Immune landscape and Clinical significance
Jingdi Zhang, Wendi Zhan, Haihong Hu, et al.
Research Square (Research Square) (2025)
Closed Access
Immune signature-based hepatocellular carcinoma subtypes may provide novel insights into therapy and prognosis predictions
Qiuxian Zheng, Qin Yang, Jiaming Zhou, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 22
Hallmark-guided subtypes of hepatocellular carcinoma for the identification of immune-related gene classifiers in the prediction of prognosis, treatment efficacy, and drug candidates
Chengbin Guo, Yuqin Tang, Yang Zhao, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 16
Potential biomarkers in the fibrosis progression of nonalcoholic steatohepatitis (NASH)
Zhaoxiang Wang, Zhicong Zhao, Yue Xia, et al.
Journal of Endocrinological Investigation (2022) Vol. 45, Iss. 7, pp. 1379-1392
Closed Access | Times Cited: 12
Identifying a distinct fibrosis subset of NAFLD via molecular profiling and the involvement of profibrotic macrophages
Weiwei He, Yinxiang Huang, Xiulin Shi, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 7
Integrated analysis of tumor and adjacent non-tumor proteomic data reveals SERPINH1 as a recurrence biomarker and drug target in hepatocellular carcinoma
Yushan Hou, Yiming Zhang, Kun Zheng, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 13, pp. 5191-5207
Open Access | Times Cited: 2
Iron-sulphur cluster biogenesis factor LYRM4 is a novel prognostic biomarker associated with immune infiltrates in hepatocellular carcinoma
Yilin Pang, Guoqiang Tan, Xunjun Yang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 15
Comprehensive analysis of metabolic pathway activity subtypes derived prognostic signature in hepatocellular carcinoma
Junyu Huo, Jinzhen Cai, Liqun Wu
Cancer Medicine (2022) Vol. 12, Iss. 1, pp. 898-912
Open Access | Times Cited: 9
HBV-infected hepatocellular carcinoma can be robustly classified into three clinically relevant subgroups by a novel analytical protocol
Zhiwei Cheng, Leijie Li, Yuening Zhang, et al.
Briefings in Bioinformatics (2023) Vol. 24, Iss. 2
Closed Access | Times Cited: 5
Head and Neck Squamous Cell Carcinoma Subtypes Based on Immunologic and Hallmark Gene Sets in Tumor and Non-tumor Tissues
Yin Ji, Xinling He, Hui Xia, et al.
Frontiers in Surgery (2022) Vol. 9
Open Access | Times Cited: 8
Subtype and prognostic analysis of immunogenic cell death-related gene signature in prostate cancer
Zhen Kang, Jiang‐Bo Sun, Fei Lin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 4
An Analysis Regarding the Association Between the Nuclear Pore Complex (NPC) and Hepatocellular Carcinoma (HCC)
Pan Huang, Yi-dou Hu, Yuan-jie Liu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 959-978
Open Access | Times Cited: 4
A breast cancer classification and immune landscape analysis based on cancer stem-cell-related risk panel
Haihong Hu, Ming‐Xiang Zou, Hongjuan Hu, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 4
Development of machine learning-based malignant pericardial effusion-related model in breast cancer: Implications for clinical significance, tumor immune and drug-therapy
Wendi Zhan, Haihong Hu, Bo Hao, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27507-e27507
Open Access | Times Cited: 1
Shared and specific competing endogenous RNAs network mining in four digestive system tumors
Yulai Tang, Aamir Fahira, Siying Lin, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 4271-4287
Open Access | Times Cited: 1
Glioma Subtypes Based on the Activity Changes of Immunologic and Hallmark Gene Sets in Cancer
Sihan Chen
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 6
Hepatitis B virus pathogenesis relevant immunosignals uncovering amino acids utilization related risk factors guide artificial intelligence-based precision medicine
Jun Huang, Chunbei Zhao, Xinhe Zhang, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
A Novel circRNA hsa_circRNA_002178 as a Diagnostic Marker in Hepatocellular Carcinoma Enhances Cell Proliferation, Invasion, and Tumor Growth by Stabilizing SRSF1 Expression
Jing Li, Ting Han, Zhenzhen Li, et al.
Journal of Oncology (2022) Vol. 2022, pp. 1-15
Open Access | Times Cited: 4
An Individualized Prognostic Signature for Clinically Predicting the Survival of Patients With Bladder Cancer
Qing Liu, Yunchao Wang, Huayu Gao, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 3
Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas
Jiasheng Wu, Jinru He, Jiheng Zhang, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 3
Identification of the Subtypes of Renal Ischemia-Reperfusion Injury Based on Pyroptosis-Related Genes
Xinhao Niu, Yin Celeste Cheuk, Xiao Li, et al.
Biomolecules (2023) Vol. 13, Iss. 2, pp. 275-275
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top